Lorella Pasquinucci
Catania, 95123, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Structure-Guided Repurposing of Approved Drugs Identifies Aprepitant and Mavorixafor as Putative δ-Opioid Receptor Agonist Candidates.
Journal: International journal of molecular sciences
Published: April 03, 2026
Targeting histone deacetylase 1: Inhibition and activation as promising therapeutic strategies for diverse disorders.
Journal: European journal of medicinal chemistry
Published: May 31, 2025
Do vitamins halt the COVID-19-evoked pro-inflammatory cytokines involved in the development of neuropathic pain?
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 22, 2025
PET imaging of the opioid system using radioligands: Synthetic approaches and translational applications.
Journal: European journal of medicinal chemistry
Published: April 01, 2025
The simultaneous activation of μ- and δ-opioid receptors by (-)-2S-LP2 rescues allodynia with the contribution of TGF-β1 signaling in a rat chronic constriction injury model.
Journal: Current research in pharmacology and drug discovery
Published: March 20, 2025
Enhancing HDAC Inhibitor Screening: Addressing Zinc Parameterization and Ligand Protonation in Docking Studies.
Journal: International journal of molecular sciences
Published: December 19, 2024
Design and Synthesis of Tetrahydropyrrolo[3,4-c]Pyrazole Sigma-1 Receptor Ligands.
Journal: ChemMedChem
Published: December 18, 2024
Design, Synthesis, and Evaluation of Novel (-)-cis-N-Normetazocine Derivatives: In Vitro and Molecular Modeling Insights.
Journal: Chemical biology & drug design
Published: September 16, 2024
Development of selective sigma-1 receptor ligands with antiallodynic activity: A focus on piperidine and piperazine scaffolds.
Journal: European journal of medicinal chemistry
Published: September 13, 2024
Last Updated: 09/26/2026